Concepedia

Theresa Fletcher

TF

Statistics

Publications

10

Citations

308

H-Index

10

Active since

2003

Affiliations

Pfizer (United States)(Current)

Washington University in St. Louis

University of Missouri–St. Louis

Office of Science

Theresa Fletcher is an author at Pfizer (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2003–2016

10

Publications

10

Discovery of Potent, Nonsystemic Apical Sodium-Codependent Bile Acid Transporter Inhibitors (Part 1)

Samuel J. Tremont, Len F. Lee, H. T. Huang et al. · Journal of Medicinal Chemistry · 2005 · 51 citations · Full text

, , +17

Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

Mark E. Schnute, Patrick O’Brien, Joe Nahra et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 50 citations · Full text

, , +10

Discovery of Potent, Nonsystemic Apical Sodium-Codependent Bile Acid Transporter Inhibitors (Part 2)

H. T. Huang, Samuel J. Tremont, Len F. Lee et al. · Journal of Medicinal Chemistry · 2005 · 48 citations · Full text

, , +15

Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation

Armin Ghobadi, Jaebok Choi, Mark A. Fiala et al. · Leukemia Research · 2016 · 37 citations · Full text

, , +12

Discovery of<i>N</i>-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2<i>S</i>,5<i>R</i>)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2<i>H</i>-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis

Peter Ruminski, Mark A. Massa, Joseph W. Strohbach et al. · Journal of Medicinal Chemistry · 2015 · 33 citations · Full text

, , +17

1–5 of 10